BioCryst

From Bhamwiki
Revision as of 10:05, 21 September 2006 by Patriarca12 (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

BioCryst Pharmaceuticals Inc. (NASDAQ:BDRX) is a pharmaceutical company based at 2190 Parkway Lake Drive in Birmingham. The company, which began in 1986, manufactures various types of perscription drugs. Its two most well-known products include a treatment of T-cell mediated disorders called BCX-1777 and another treatment for T-cell mediated autoimmune diseases called BCX-4208.

The CEO and Chairman of the Board is Dr. Charles E. Bugg, who was one of the companies co-founders in 1986. Set to retire in 2007, under Brugg's leadership, the company went public in 1994 seeing moderate profits.


References

  • BioCryst Pharmaceuticals Inc. corporate spotling at NASDAQ. - Accessed September 21, 2006
  • Hubbard, Russell. (September 21, 2006) "BioCryst says CEO will retire in 2007." Birmingham News.

External links

Retrieved from "http://bhamwiki.com/w/index.php?title=BioCryst&oldid=9055"